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INTRODUCTION 
Neuronal cell damage and death is 
mediated through a spectrum of genetic and 
biological processes. In addition to Genetic 
causes, excessive amounts of toxic reagents 
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ABSTRACT 
Background and aims: Hearing loss (HL) happens due to the genetic or environmental 
causes or both. Risk factors include congenital infections and congenital deformities of 
auricle and ear duct. The present study was performed to briefly explain the genetics, 
molecular biology and epidemiology of HL in Middle East especially in Iran. 
Methods: An intense an comprehensive literature search was prformed through heading 
journals in the field. All data was organized using Mendeley software and incorporated to 
the text as required. 
Results: While the etiology of 25% of HL cases remains indistinct, it is estimated that at 
least 50% of pre lingual HL cases have a genetic cause. About 70% of genetic HL cases 
are non Syndromic (NSHL) without anomaly, whereas the remaining 30% are 
Syndromic. Autosomal recessive non-syndromic hearing loss forms (ARNSHL) are the 
severest forms of congenital HL with defect in cochlea. In addition to X-linked (DFNX), 
autosomal dominant (DFNA), autosomal recessive (DFNB) and Y-linked (DFNY) 
inheritance patterns, HL can be inherited through mitochondrial genes including  
MT-RNR1 and MT-TS. At least 120 genes have been reported to be associated with HL. 
Among them, mutations in connexin 26 (GJB2) have been shown to play a very 
important role in developing ARSNSHL in many populations depending on geographical 
location and ethnicity. In Caucasians and Spainish/Italian populations, 50% and 79% of 
HL cases have respectively been reported to be occurred due to mutations in GJB2 gene. 
Conclusion: In the Middle East, the prevalence seems different as an average of 14-20% 
of the HL in several region of Iran is due to mutation in GJB2 gene. Alternatively similar 
studies showed the prevalence of GJB2 mutations around 25% and 6.1% in Turkey and 
Pakistani populations respectively. 
 
Keywords: Hearing loss, Iranian population, GJB2. 
R
ev
iew
 a
r
ticle
 
Karami-Eshkaftaki R, et al. Molecular genetics and epidemiologic aspects 
167 
and free radicals have detrimental effects on 
neurons.
1,2
 
According to WHO global estimates on 
prevalence of hearing loss, disabling hearing 
refers to hearing loss greater than 40 dB in the 
better hearing ear in adults (15 years or older) 
and greater than 30 dB in the better hearing 
ear in children (0 to 14 years). Hearing loss 
(HL) is one the most common sensory 
disorders that affect about 4% of people under 
45 years. HL is a highly heterogeneous 
disorder containing a broad spectrum of 
clinical presentations including conductive or 
sensory neural, congenital or late onset, and 
syndromic or non-syndromic.
3
 In addition to 
the great economic burden on families, this 
disorder also has many psychological and 
emotional effects and the main problem in the 
distinction of deafness is heterogeneity.
4
 
The normal hearing threshold is 15 dB 
(decibel) and the level of a regular 
conversation is 45 to 60 dB.
5
 Based on 
different criteria HL can be divided to various 
types including severity (mild: 20-39 dB, 
moderate: 40-69 dB, severe: 70-89 dB, or 
profound: ≥90 dB), age of onset (pre or post 
lingual, Presbycusis or age-related HL 
(ARHL) types), origin (sensorineural, 
conductive or mixed) and attendance or 
absence of associated features (non-syndromic 
or syndromic).
6
 Among them, Syndromic HL 
correlates with physical problems and  
non-syndromic genetic HL is without ever 
complexity.
5
 
Conductive HL generally occurs by the 
external and middle ear congenital 
abnormalities like atrophy and dysplasia, duct 
blockage, impacted cerumen, otitis and middle 
ear and Tympanic membrane deficiency.
7
 
However, congenital causes and infections 
like measles, cytomegalovirus and bacterial 
meningitis are the most common causes of 
Sensorineural HL.
5
 
It is known that HL happens due to the 
genetic or environmental causes or both.
8
 
Based on the cause of sensorineural deafness, 
HL is classified into three major forms 
including acquired, genetic and unknown: 
1. Acquired HL: In addition to genetic 
background that has an important role on HL 
occurrence, infectious and pharmaceutical 
agents (e.g. teratogens) could influence the 
sense of hearing. Risk factors may include 
congenital infections (e.g. smallpox, 
toxoplasmosis, syphilis, measles, herpes virus 
orcytomegalovirus) and congenital deformities 
of auricle and ear duct.
5,9
 Prematurity and low 
birth weight (less than 1500 g) and high blood 
bilirubin during birth are other important 
threats.
5
 Moreover, the HL may pathologically 
originate postnatal and may be due to 
infections and bacterial meningitis, mumps, 
otitis media, blood infection, autotoxic drugs 
such as aminoglycosides and head injury or 
skull fracture that result to anesthesia;
5
  
2. Mixed HL: In which the conductive  
and sensorineural problems are seen 
simultaneously;
5
 3. Genetic HL: In the early 
18
th
 century, William Wild, the Irish 
physician, discovered the inheritance of HL. 
He discriminated between dominant and 
recessive forms and also described HL in men 
with X-linked transmission.
5
 
While the etiology of 25% of HL cases 
remains indistinct, it is estimated that at least 
50% of pre-lingual HLs have a genetic cause. 
Also, about 70% of genetic HL cases are  
non-syndromic (NSHL) without anomaly, 
whereas the remaining (30%) are Syndromic. 
To date, over 400 Syndromic forms of HL 
have been introduced as Usher syndrome and 
Pendred syndrome which together are the 
most common instants.
10
 Therefore, the 
genetic study of HL has noteworthy benefits 
for patients that are as follows: 
A. Determining a treatment strategy 
including medical and nonmedical decisions 
(eg.cochlear implant); B. Carrier and prenatal 
diagnosing; C. Performing genetic counseling 
before marriage, especially when there  
is heterogeneity that freight different mutated 
genes; D. Eliminating unnecessary 
International Journal of Epidemiologic Research, 2017; 4(2): 166-172. 
168 
experiments and investigations; E. Forecasting 
for the going state of the disease. 
Genetic evaluation should be carried out 
for children with newly recognized HL 
especially if no specific cause is determined. 
For example, although genetic evaluation of 
the family of a child with HLof meningitis is 
unnecessary, they may need to assure not 
transmitting the disease to the next birth. 
Various steps of Genetic evaluation include:
4
 
1. Revising the complete medical history of 
prenatal, neonatal and growth and 
development; 2. Completing physical test of 
patients and other family members; 3. 
Assessing the genetics, cellular and molecular 
diagnosis. 
HL is one of the concerns about public 
health in developing countries as two thirds of 
HL patients live in these countries.
11
 The 
worldwide incidence of genetic HL ranges 
from 1 in 2000 up to 1 in 650 live births.
12
 
Generally 1.06 in 1000 cases suffers from pre-
lingual hearing loss disorder.
13
 About 80% of 
the hereditary deafness cases are non-
syndromic and predominantly inherited as 
autosomal recessive.
14
 
Middle East and North Africa  
region are known to have the lowest 
prevalence (5.9%, 3.0%-11.5%) of hearing 
problem(≥35 dB) for adults above 15 years. 
However, the highest rate of hearing 
impairment (≥35 dB) in adults has been 
reported in the South Asian region (21.4%) 
following by Eastern Europe and Central Asia 
(13.9%, 2.9%-51.0%).
15
 
Since people in the developing countries 
do not have the same health services as in the 
western countries do, it seems very important 
to study causes of HL in these countries. As an 
example in the Middle East, there are several 
comprehensive studies performed in Iran. 
According to the statistics results, there are 
nearly 450000 HL patients but only 121000 of 
them have been identified by the State 
Welfare Organization.
13
 
This data reflects the necessity of family 
orientation programs to control the 
consanguineous marriages which is as high as 
38.6% in this area.
13,16
 
As sanitary indexes are improved, the 
role of genetics in HL is becoming more 
important.
17,18
 So far, over 400 syndromes 
with HL have been mentioned in OMIM. 
Among them, the most common syndromes 
are Usher syndrome and Pendred syndrome 
followed by Alport syndrome, Waardenburg 
syndrome, Branchio-oto-renal syndrome and 
Stickler Syndrome(10)and it is estimated that 
approximately 1% of human genes (200 to 
250 genes) are responsible for inherited HL.
13
 
Nomenclature schemes for HL loci use 
the symbol DFN, followed by the pattern  
of inheritance such as X-linked (DFNX), 
autosomal dominant (DFNA), autosomal 
recessive (DFNB) and Y-linked (DFNY). 
Moreover, hierarchical numbering system 
describes the individual members e.g. DFNB1 
which is the first identified locus causing 
autosomal recessive HL.
8
 
The majority of genetic HL is without 
any abnormality in other organs categorized 
as non-syndromic HL (NSHL) and has 
various mode of inheritance.
6
 More than 100 
loci and 55 genes may be involved in non 
syndromic HL.
13
 
Autosomal recessive non-syndromic 
hearing loss forms (ARNSHL) described for 
the first time in 1846, and they are the severest 
forms of congenital HL with defect in 
cochlea.
19
 ARNSHL are commonly  
pre-lingual, more severe and exclusively 
sensorineural forms of HL.
20
 
The most studied genes involve in 
ARNSHL are MYO15A (in DFNB3 locus), 
SLC26A4 (DFNB4), CDH23 (DFNB12), 
TMC1 (DFNB7/11), OTOF (DFNB9), 
TMPRSS3 (DFNB8/10) and TMHS 
(DFNB67). However, due to the prevalence 
and importance, the majority of researches 
have focused on the DFNB1 loci.
21
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Guilford and co-workersin 1994 
introduced DFNB1 as the first locus of 
ARNSHL on chromosome 13q12-q13z.
8
 Most 
of consanguine families of different kinfolk 
were related to the DFNB1 locus.
22
 
Recent studies have shown that the 
inheritance of 75% nonsyndromic HL are 
autosomal recessive, 10-20% autosomal 
dominant and 1-5% are X-linked 
recessive.
13,23
 
Common phenotypes of autosomal 
dominant form of deafness consist of late 
onset, mild and progressive forms of HL. 
Almost 25 genes and > 60 loci have been 
reported for autosomal dominant non 
syndromic hearing loss (ADNSHL). Although 
there is not enough evidence on the role of 
mutations in ADNSHL, mutations in some 
genes including WFS1, KCNQ4, COCH and 
GJB2 have been recommended to be 
involved.
10,24,25
 
The X-linked forms of deafness have 
been presented either prelingual or progressive 
in different families. The frequency of  
X-linked forms of HL (DFNX) is less than 
ARNSHL and ADNSHL and 5 loci and  
3 genes (POU3F4, SMPX and PRPS1) have 
been suggested for DFNX.
26
 The only one 
locus on chromosome Y, is PCDH11Y 
(encoding Protocadherin) and has been 
reported to be involved in DFNY1 in a large 
Chinese family (7 generations) with the age of 
onset ranging from 7 to 27 years.
26 
Molecular Pathology of HL is a scientific 
discipline dealing with the development of 
molecular approaches to study, diagnosis and 
classification of various human diseases 
including cancer, infectious diseases and 
genetic disorders such as HL.
27,28
 
In healthy individuals, cells contain 
thousands of molecules of mitochondrial 
DNA with identical sequence and genotype, a 
phenomenon known as homoplasmy. 
However, in many mitochondrial diseases, 
mutations often co-exist with their wild type 
in different proportions which are known as 
heteroplasmy. Heteroplasmy varies from one 
tissue to another and even within the cells of a 
tissue. There are only a few genes associated 
with mitochondrial HL; 2 examples are  
MT-RNR1 that encodes mitochondrial  
12S ribosomal RNA and MT-TS1 which 
encodes mitochondrial transfer RNA serine 1. 
Both of these genes are known to cause 
nonsyndromic mitochondrial HL.
29
 
At least 120 genes have been reported to 
be associated with HL. Gap junction is a 
major communication system for the rapid 
exchange of different component between 
neighbor cells. Therefore, it also has an 
important role in auditory transduction, 
thorough recycling endolymphatic potassium 
ions. Connexin 26 (GJB2) expressed in a 
variety of tissues such as cochlea which is a 
member of family encoding the gap junction 
proteins.
24,30,31
 
Although several genes involve in 
causing deafness, mutations in connexin 26 
(GJB2) have been shown to play a very 
important role in developing ARSNSHL in 
many populations depending on geographical 
location and ethnicity.
8,24,32-35
 In Caucasians 
and Spainish/Italian populations, 50% and 
79% of HL shave respectively been reported 
to be occurred due to mutations in GJB2 
gene.
21,36
 
In the Middle East, however, the 
prevalence seems different. For instance a 
comprehensive study on HL in Iran showed 
that an average of 14-20% of the HL in 
several region of Iran is due to mutation  
in GJB2 gene.
21,36,37
 This finding indicates  
that the involvement of this gene in Western 
populations is higher than Iranian 
population.
37-39
 Furthermore, different 
geographical areas in Iran showed different 
abundance. The rate of mutations in GJB2 
gene is respectively 38%,22% and 9% in the 
North (e.g. Golestan, Gilan, Mazandaran), 
North West (e.g. Azerbaijan) and North East 
(Gorgan) of Iran, respectively.
37-39
 
Alternatively similar studies showed the 
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prevalence of GJB2 mutations around 25% 
and 6.1% in Turkey and Pakistani populations, 
respectively.
40,41
 
 
CONCLUSION 
One of the most common sensory defects 
influencing human is HL. After the mental 
retardation, HL is the most common adverse 
sensory neural defect in humans.
37,39
 A severe 
early HL restricts childhood from acquisition 
speech ability and literacy. The later onset of 
HL can also affect the quality of life 
negatively.
42
 
HL is classified base on multiple criteria. 
Genetic factors can be involved in 50% of the 
cases. Nonsyndromic HL can be transmitted 
through any Mendelian inheritance patterns, 
but the majority of them are ARNSHL. 
Almost 50 genes are involved in HL. Also 
approximately 200 to 250 genes have been 
predicted to cause HL.
37,39
 
One of the problems during genetic 
counseling is low public education and 
understanding of the genetic causes of HL in 
the Middle East(4). The researches have 
determined at least10 genes and several loci in 
nearly 2000 HL family in Iran. However, in 
Iran, most studies on ARNSHL have been 
centralized on DFNB1 (GJB2) mutation, as 
about 18% of HL are result of GJB2 gene 
mutations. The rate of GJB2 gene mutations in 
Iran is less than Caucasian populations and 
more studies would reveal the role of other 
loci in ARNSHL pathogenesis in Iranian 
population. Understanding the genetic origin 
of HL and the molecular mechanism of 
hearing process are important in modulating 
genetic counseling and new treatments.
37,39
 It 
will also help to design therapeutic strategies 
to cure HL using recent advances such as stem 
cell therapy.
43
 
Hopefully, new technologies like next 
generation sequencing can help detecting new 
genes for HL in future. Recognizing these 
factors can definitely help families in reducing 
the rate of disease. The present study was 
performed to explain briefly the genetics, 
molecular biology and epidemiology of HL in 
Middle East especially in Iran aiming to help 
better genetic screening, diagnosing disease 
and genetic counseling. 
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